Interpreting Net Survival: What We Estimate Versus What We Think We Estimate

2026-03-01

AI Summary

This study re-examines the conventional definition of net survival—commonly estimated via the Pohar-Perme estimator—under the widely adopted assumption that cancer patients experience the same non-cancer mortality risk as the general population. Challenging this assumption, the authors propose a theoretical framework decomposing total mortality into cancer-related, baseline health–related, treatment-induced, and background non-cancer components. Through mathematical derivation and empirical analysis, they demonstrate that the Pohar-Perme estimator inherently incorporates non-cancer mortality beyond background rates and thus should not be interpreted as a causal counterfactual quantity; rather, it represents a conditional survival probability adjusted only for background mortality. Empirical results reveal that for cancers such as head and neck, the relative risk of non-cancer mortality can exceed 4.0, leading to substantial underestimation of true cancer-specific survival whenever this risk surpasses unity, thereby exposing a systematic bias in current interpretations of net survival.

Technology Category

• Reasoning under Uncertainty: Causality
• Machine Learning: Calibration & Uncertainty Quantification
• Search and Optimization: Non-convex Optimization

Application Category

• Social Networks and Social Media: Fairness and bias in social network and social media analysis
• User Modeling, Personalization and Recommendation: Attacks and countermeasures in recommendation systems
• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking

Abstract

Net survival is conventionally defined as ``survival if cancer were the only possible cause of death'', an estimand corresponding to cancer-specific mortality alone. The Pohar Perme estimator targets this by removing general population other-cause mortality from observed total mortality, but achieves it only when cancer patients experience the same other-cause mortality as the general population. However, cancer patients often experience elevated other-cause mortality due to baseline health differences and treatment-induced effects. Using recent theoretical work decomposing total mortality into four components (cancer deaths, baseline health differences, treatment-induced other-cause deaths, and general population other-cause mortality), we show that the Pohar Perme estimator delivers the sum of cancer deaths, baseline differences, and treatment-induced deaths, falling short of its intended estimand whenever either source of excess is present. From Botta \textit{et al}, we present empirical evidence showing relative risk of other-cause deaths ranging from 1.0 (colorectal cancer) to 4.0+ (head and neck cancers), and calculations demonstrating that net survival can substantially underestimate cancer-specific survival probability when relative risk exceeds 1.0. Critically, treatment-induced other-cause deaths represent irreducible causal pathways from cancer to death that cannot be eliminated through better stratification. We recommend interpreting net survival as ``survival where general population other-cause mortality is removed'' rather than as a causal counterfactual, and call for more precise language in cancer epidemiology.

Problem

• net survival
• cancer-specific mortality
• other-cause mortality
• Pohar Perme estimator
• causal interpretation

Innovation

• net survival
• Pohar Perme estimator
• cancer-specific mortality
• excess other-cause mortality
• causal interpretation